9th Annual Report and Survey of Biopharmaceutical Manufacturing

  • May 2012
  • -
  • BioPlan Associates, Inc.
  • -
  • 471 pages

Improve your decision-making in biomanufacturing capacity, production, and performance with this essential reference tool. With over 200 data graphs and tables with in-depth research on global biomanufacturers, you can find out how budgetary trends are impacting the economic environment today. This publication will allow you to effectively evaluate differences between US, Europe and ROW, as well as Biomanufacturers and CMOs. You’ll also get analysis on how suppliers’ strategies are changing in today’s industry.

Coverage includes:

• Biosimilars pipeline in development
• In-depth analysis of key data, capacity, production trends, and benchmarks
• Budget trends and impact of current economic environment
• Expression system advances
• Downstream purification problems and issues
• Current and projected industry bottlenecks
• Capacity utilization and current production levels
• How capacity bottlenecks are being resolved
• Production trends and implications for industry
• Outsourcing trends
• International offshoring through 2017
• Range of titres, growth
• Disposables: Spending growth; downstream uses; L&E’s; reasons for increasing/ restricting; budget increases; vendor satisfaction
• Disposables: Compare innovators vs CMOs & US vs Europe
• Batch failure rates & trends
• Selecting a CMO—Problems & solutions
• Quality management & PAT implementation
• Hiring and employment growth
• Supplier growth rates
• Much more...

By the numbers:

• 302 Biomanufacturers and CMOs surveyed
• 185 Direct industry suppliers
• 29 Countries represented
• 471 Pages
• 12 Chapters
• 208 Graphs and 21 tables
• 12 Subject Matter Experts providing analysis
• 22 Independent Sponsoring Organizations

Table Of Contents

Table of contents

Chapter 1 Introduction and Industry Overview
Chapter 2 Demographics
Chapter 3 Emerging Issues: Operational Changes, Budgets, Expression Systems, more
Chapter 4 Capacity Utilization
Chapter 5 Current Capacity Constraints
Chapter 6 Future Capacity Expansions
Chapter 7 Outsourcing Trends
Chapter 8 Disposables and Single-Use Systems
Chapter 9 Downstream Issues
Chapter 10 Quality Issues, Batch Failures, and PAT
Chapter 11 Hiring, Employment Growth, and Training
Chapter 12 Suppliers to Biopharmaceutical Manufacturing

Statistical information from this edition

14.4% outsourced jobs in manufacturing
19.2% Average sales growth rate for CMOs to biomanufacturing
96.8% of biomanufacturers demanding better working relationships from their CMOs
47.2% Evaluating membrane filtration technologies
47.1% Exploring disposable UF systems
$252,000 is the average facility budget for single use bioreactors
46.2% Using disposables primarily to eliminate cleaning requirements
40.9% of biomanufacturers demanding new bio-assays for lot release
39.2 of biomanufacturers used single-use devices in clinical manufacturing operations
66.0% of European biomanufacturers improved their downstream production operations
27.7% are demanding better disposable bioreactors
50.7% having difficulty hiring process development staff
51.8% are actively considering alternatives to protein A
66.8% Biomanufacturers still focused on cost-cutting
42.1% Evaluating membrane filtration technologies
…plus hundreds of facts and graphs!

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Biologic Therapeutic Drugs: Technologies and Global Markets

Biologic Therapeutic Drugs: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global biologics market totaled $200.6 billion in 2013 and is expected to grow to nearly $234 billion in 2014. The total market is expected to grow to $386.7 billion by the end of ...

Antibody Drugs: Technologies and Global Markets

Antibody Drugs: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for antibody drugs was worth nearly $63.4 billion in 2013. This market is expected to grow at a compound annual growth rate (CAGR) of 12.2% between 2014 and 2019 resulting ...

Biosimilars: Global Markets

Biosimilars: Global Markets

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global biosimilars market was valued at $1.8 billion in 2013 and nearly $2.0 billion in 2014. The market is expected to reach nearly $4.0 billion by 2019, with a compound annual growth ...

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.